Luuk B Hilbrands

InstitutionRadboud university medical center
AddressThe
Netherlands
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 11 Covid-19 publications, with a maximum of 2 publications in August 2020 and November 2020
    All Publications
    Bar chart showing 105 publications over 20 distinct years, with a maximum of 16 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hilbrands LB, Duivenvoorden R, Vart P, Franssen CFM, Hemmelder MH, Jager KJ, Kieneker LM, Noordzij M, Pena MJ, Vries H, Arroyo D, Covic A, Crespo M, Goffin E, Islam M, Massy ZA, Montero N, Oliveira JP, Roca Muñoz A, Sanchez JE, Sridharan S, Winzeler R, Gansevoort RT. Erratum to: COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration. Nephrol Dial Transplant. 2021 Sep 27; 36(10):1962. PMID: 34075410.
      Citations:    Fields:    
    2. Kho MML, Reinders MEJ, Baan CC, van Baarle D, Bemelman FJ, Diavatopoulos DA, Gansevoort RT, van der Klis FRM, Koopmans MPG, Messchendorp AL, van der Molen RG, Remmerswaal EBM, Rots N, Vart P, de Vries RD, Hilbrands LB, Sanders JF. The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant. Nephrol Dial Transplant. 2021 08 27; 36(9):1761-1764. PMID: 34450647.
      Citations: 3     Fields:    Translation:Humans
    3. Kho MML, Reinders MEJ, Baan CC, van Baarle D, Bemelman FJ, Diavatopoulos DA, Gansevoort RT, van der Klis FRM, Koopmans MPG, Messchendorp AL, van der Molen RG, Remmerswaal EBM, Rots N, Vart P, de Vries RD, Hilbrands LB, Sanders JF. The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis, or living with a kidney transplant - a prospective, controlled, multicenter observational cohort by the REnal patients COVID-19 VACcination (RECOVAC) consortium COVID-19 VACcination (RECOVAC) consortium. Nephrol Dial Transplant. 2021 May 26. PMID: 34038554.
      Citations: 3     Fields:    
    4. Noordzij M, Vart P, Duivenvoorden R, Franssen CFM, Hemmelder MH, Jager KJ, Hilbrands LB, Gansevoort RT. Pitfalls when comparing COVID-19-related outcomes across studies-lessons learnt from the ERACODA collaboration. Clin Kidney J. 2021 Mar; 14(Suppl 1):i14-i20. PMID: 33796283.
      Citations: 3     
    5. Gansevoort RT, Hilbrands LB. CKD is a key risk factor for COVID-19 mortality. Nat Rev Nephrol. 2020 12; 16(12):705-706. PMID: 32848205.
      Citations: 36     Fields:    Translation:HumansPHPublic Health
    6. Rother N, Yanginlar C, Lindeboom RGH, Bekkering S, van Leent MMT, Buijsers B, Jonkman I, de Graaf M, Baltissen M, Lamers LA, Riksen NP, Fayad ZA, Mulder WJM, Hilbrands LB, Joosten LAB, Netea MG, Vermeulen M, van der Vlag J, Duivenvoorden R. Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons. Cell Rep Med. 2020 12 22; 1(9):100146. PMID: 33377122.
      Citations: 6     
    7. Hilbrands LB, Duivenvoorden R, Vart P, Franssen CFM, Hemmelder MH, Jager KJ, Kieneker LM, Noordzij M, Pena MJ, Vries H, Arroyo D, Covic A, Crespo M, Goffin E, Islam M, Massy ZA, Montero N, Oliveira JP, Roca Muñoz A, Sanchez JE, Sridharan S, Winzeler R, Gansevoort RT. COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration. Nephrol Dial Transplant. 2020 11 01; 35(11):1973-1983. PMID: 33151337.
      Citations: 73     Fields:    Translation:Humans
    8. Buijsers B, Yanginlar C, de Nooijer A, Grondman I, Maciej-Hulme ML, Jonkman I, Janssen NAF, Rother N, de Graaf M, Pickkers P, Kox M, Joosten LAB, Nijenhuis T, Netea MG, Hilbrands L, van de Veerdonk FL, Duivenvoorden R, de Mast Q, van der Vlag J. Increased Plasma Heparanase Activity in COVID-19 Patients. Front Immunol. 2020; 11:575047. PMID: 33123154.
      Citations: 28     Fields:    Translation:HumansCellsPHPublic Health
    9. Schoot TS, Kerckhoffs APM, Hilbrands LB, van Marum RJ. Immunosuppressive Drugs and COVID-19: A Review. Front Pharmacol. 2020; 11:1333. PMID: 32982743.
      Citations: 17     
    10. Meijers B, Hilbrands LB. The clinical characteristics of coronavirus-associated nephropathy. Nephrol Dial Transplant. 2020 08 01; 35(8):1279-1281. PMID: 32871591.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    11. Maggiore U, Abramowicz D, Crespo M, Mariat C, Mjoen G, Peruzzi L, Sever MS, Oniscu GC, Hilbrands L, Watschinger B. How should I manage immunosuppression in a kidney transplant patient with COVID-19? An ERA-EDTA DESCARTES expert opinion. Nephrol Dial Transplant. 2020 06 01; 35(6):899-904. PMID: 32441741.
      Citations: 28     Fields:    Translation:HumansCellsPHPublic Health
    12. Hermsen M, de Bel T, den Boer M, Steenbergen EJ, Kers J, Florquin S, Roelofs JJTH, Stegall MD, Alexander MP, Smith BH, Smeets B, Hilbrands LB, van der Laak JAWM. Deep Learning-Based Histopathologic Assessment of Kidney Tissue. J Am Soc Nephrol. 2019 10; 30(10):1968-1979. PMID: 31488607.
      Citations: 47     Fields:    Translation:Humans
    13. Mihajlovic M, Hariri S, Westphal KCG, Janssen MJ, Oost MJ, Bongiovanni L, van den Heuvel LP, de Bruin A, Hilbrands LB, Masereeuw R. Safety evaluation of conditionally immortalized cells for renal replacement therapy. Oncotarget. 2019 Sep 03; 10(51):5332-5348. PMID: 31523392.
      Citations: 1     Fields:    
    14. Ergün M, Özdemir-van Brunschot DMD, Donders RART, Hilbrands LB, Hoitsma AJ, Warlé MC. Prolonged Duration of Brain Death was Associated with Better Kidney Allograft Function and Survival: A Prospective Cohort Analysis. Ann Transplant. 2019 Mar 15; 24:147-154. PMID: 30872563.
      Citations: 2     Fields:    Translation:Humans
    15. Mihajlovic M, Wever KE, van der Made TK, de Vries RBM, Hilbrands LB, Masereeuw R. Are cell-based therapies for kidney disease safe? A systematic review of preclinical evidence. Pharmacol Ther. 2019 05; 197:191-211. PMID: 30677474.
      Citations: 3     Fields:    Translation:HumansAnimals
    16. Tielemans MM, van Boekel GAJ, van Gelder T, Tjwa ET, Hilbrands LB. Immunosuppressive drugs and the gastrointestinal tract in renal transplant patients. Transplant Rev (Orlando). 2019 04; 33(2):55-63. PMID: 30473173.
      Citations: 5     Fields:    Translation:Humans
    17. Pieterse E, Rother N, Yanginlar C, Gerretsen J, Boeltz S, Munoz LE, Herrmann M, Pickkers P, Hilbrands LB, van der Vlag J. Cleaved N-terminal histone tails distinguish between NADPH oxidase (NOX)-dependent and NOX-independent pathways of neutrophil extracellular trap formation. Ann Rheum Dis. 2018 12; 77(12):1790-1798. PMID: 30120096.
      Citations: 27     Fields:    Translation:HumansCells
    18. Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG. Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure. J Am Soc Nephrol. 2018 09; 29(9):2279-2285. PMID: 30049681.
      Citations: 3     Fields:    Translation:Humans
    19. Kers J, Peters-Sengers H, Heemskerk MBA, Berger SP, Betjes MGH, van Zuilen AD, Hilbrands LB, de Fijter JW, Nurmohamed AS, Christiaans MH, Homan van der Heide JJ, Debray TPA, Bemelman FJ. Prediction models for delayed graft function: external validation on The Dutch Prospective Renal Transplantation Registry. Nephrol Dial Transplant. 2018 07 01; 33(7):1259-1268. PMID: 29462353.
      Citations: 6     Fields:    Translation:Humans
    20. Wirken L, van Middendorp H, Hooghof CW, Bremer TE, Hopman SPF, van der Pant KAMI, Hoitsma AJ, Hilbrands LB, Evers AWM. Development and feasibility of a guided and tailored internet-based cognitive-behavioural intervention for kidney donors and kidney donor candidates. BMJ Open. 2018 06 30; 8(6):e020906. PMID: 29961018.
      Citations:    Fields:    Translation:Humans
    21. Bunthof KLW, Hazzan M, Hilbrands LB. Review: Management of patients with kidney allograft failure. Transplant Rev (Orlando). 2018 07; 32(3):178-186. PMID: 29628415.
      Citations: 5     Fields:    Translation:Humans
    22. Geneugelijk K, Niemann M, Drylewicz J, van Zuilen AD, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Hack CE, van Reekum FE, Verhaar MC, Kamburova EG, Bots ML, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed A, Lardy JNM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Spierings E. PIRCHE-II Is Related to Graft Failure after Kidney Transplantation. Front Immunol. 2018; 9:321. PMID: 29556227.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    23. Mihajlovic M, Fedecostante M, Oost MJ, Steenhuis SKP, Lentjes EGWM, Maitimu-Smeele I, Janssen MJ, Hilbrands LB, Masereeuw R. Role of Vitamin D in Maintaining Renal Epithelial Barrier Function in Uremic Conditions. Int J Mol Sci. 2017 Nov 26; 18(12). PMID: 29186865.
      Citations: 9     Fields:    Translation:HumansCells
    24. Bunthof KLW, Verhoeks CM, van den Brand JAJG, Hilbrands LB. Graft intolerance syndrome requiring graft nephrectomy after late kidney graft failure: can it be predicted? A retrospective cohort study. Transpl Int. 2018 02; 31(2):220-229. PMID: 29082567.
      Citations: 1     Fields:    Translation:Humans
    25. Özdemir-van Brunschot DMD, Scheffer GJ, van der Jagt M, Langenhuijsen H, Dahan A, Mulder JEEA, Willems S, Hilbrands LB, Donders R, van Laarhoven CJHM, d'Ancona FA, Warlé MC. Quality of Recovery After Low-Pressure Laparoscopic Donor Nephrectomy Facilitated by Deep Neuromuscular Blockade: A Randomized Controlled Study. World J Surg. 2017 11; 41(11):2950-2958. PMID: 28608013.
      Citations: 9     Fields:    Translation:Humans
    26. Özdemir-van Brunschot DMD, Scheffer GJ, van der Jagt M, Langenhuijsen JF, Dahan A, Mulder JEEA, Willems S, Hilbrands LB, Donders R, van Laarhoven CJHM, d'Ancona FA, Warlé MC. Erratum to: Quality of Recovery After Low-Pressure Laparoscopic Donor Nephrectomy Facilitated by Deep Neuromuscular Blockade: A Randomized Controlled Study. World J Surg. 2017 11; 41(11):2949. PMID: 28821918.
      Citations:    Fields:    
    27. Rother N, Pieterse E, Lubbers J, Hilbrands L, van der Vlag J. Acetylated Histones in Apoptotic Microparticles Drive the Formation of Neutrophil Extracellular Traps in Active Lupus Nephritis. Front Immunol. 2017; 8:1136. PMID: 28959262.
      Citations: 17     Fields:    
    28. Mihajlovic M, van den Heuvel LP, Hoenderop JG, Jansen J, Wilmer MJ, Westheim AJF, Allebes WA, Stamatialis D, Hilbrands LB, Masereeuw R. Allostimulatory capacity of conditionally immortalized proximal tubule cell lines for bioartificial kidney application. Sci Rep. 2017 08 02; 7(1):7103. PMID: 28769101.
      Citations: 3     Fields:    Translation:HumansCells
    29. Pieterse E, Rother N, Garsen M, Hofstra JM, Satchell SC, Hoffmann M, Loeven MA, Knaapen HK, van der Heijden OWH, Berden JHM, Hilbrands LB, van der Vlag J. Neutrophil Extracellular Traps Drive Endothelial-to-Mesenchymal Transition. Arterioscler Thromb Vasc Biol. 2017 07; 37(7):1371-1379. PMID: 28495931.
      Citations: 51     Fields:    Translation:HumansAnimalsCells
    30. Tutakhel OAZ, Moes AD, Valdez-Flores MA, Kortenoeven MLA, Vrie MVD, Jelen S, Fenton RA, Zietse R, Hoenderop JGJ, Hoorn EJ, Hilbrands L, Bindels RJM. NaCl cotransporter abundance in urinary vesicles is increased by calcineurin inhibitors and predicts thiazide sensitivity. PLoS One. 2017; 12(4):e0176220. PMID: 28430812.
      Citations: 7     Fields:    Translation:HumansAnimals
    31. van den Hoogen MW, Steenbergen EJ, Baas MC, Florquin S, Hilbrands LB. Absence of Intragraft B Cells in Rejection Biopsies After Rituximab Induction Therapy: Consequences for Clinical Outcome. Transplant Direct. 2017 Apr; 3(4):e143. PMID: 28405599.
      Citations: 3     
    32. Bruintjes MH, Braat AE, Dahan A, Scheffer GJ, Hilbrands LB, d'Ancona FC, Donders RA, van Laarhoven CJ, Warlé MC. Effectiveness of deep versus moderate muscle relaxation during laparoscopic donor nephrectomy in enhancing postoperative recovery: study protocol for a randomized controlled study. Trials. 2017 03 04; 18(1):99. PMID: 28259181.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    33. Wirken L, van Middendorp H, Hooghof CW, Sanders JS, Dam RE, van der Pant KAMI, Berendsen ECM, Wellink H, Dackus HJA, Hoitsma AJ, Hilbrands LB, Evers AWM. Pre-donation cognitions of potential living organ donors: the development of the Donation Cognition Instrument in potential kidney donors. Nephrol Dial Transplant. 2017 03 01; 32(3):573-580. PMID: 28160472.
      Citations: 2     Fields:    Translation:Humans
    34. Maicas N, van der Vlag J, Bublitz J, Florquin S, Bakker-van Bebber M, Dinarello CA, Verweij V, Masereeuw R, Joosten LA, Hilbrands LB. Human Alpha-1-Antitrypsin (hAAT) therapy reduces renal dysfunction and acute tubular necrosis in a murine model of bilateral kidney ischemia-reperfusion injury. PLoS One. 2017; 12(2):e0168981. PMID: 28235038.
      Citations: 6     Fields:    Translation:HumansAnimals
    35. Maggiore U, Budde K, Heemann U, Hilbrands L, Oberbauer R, Oniscu GC, Pascual J, Schwartz Sorensen S, Viklicky O, Abramowicz D. Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES working group. Nephrol Dial Transplant. 2017 02 01; 32(2):216-223. PMID: 28186535.
      Citations: 26     Fields:    Translation:Humans
    36. Dobrowolski LC, van Huis M, van der Lee JH, Peters Sengers H, Liliën MR, Cransberg K, Cornelissen M, Bouts AH, de Fijter JW, Berger SP, van Zuilen A, Nurmohamed SA, Betjes MHG, Hilbrands L, Hoitsma AJ, Bemelman FJ, Paul Krediet CT, Groothoff JW. Epidemiology and management of hypertension in paediatric and young adult kidney transplant recipients in The Netherlands. Nephrol Dial Transplant. 2017 02 01; 32(2):402. PMID: 28186547.
      Citations: 1     Fields:    
    37. Hinten F, Hilbrands LB, Meeuwis KA, van Bergen-Verkuyten MC, Slangen BF, van Rossum MM, Rahamat-Langendoen J, Massuger LF, de Hullu JA, Melchers WJ. Improvement of Gynecological Screening of Female Renal Transplant Recipients by Self-Sampling for Human Papillomavirus Detection. J Low Genit Tract Dis. 2017 Jan; 21(1):33-36. PMID: 27741039.
      Citations:    Fields:    Translation:Humans
    38. van Ittersum FJ, Hemke AC, Dekker FW, Hilbrands LB, Christiaans MH, Roodnat JI, Hoitsma AJ, van Diepen M. Increased risk of graft failure and mortality in Dutch recipients receiving an expanded criteria donor kidney transplant. Transpl Int. 2017 Jan; 30(1):14-28. PMID: 27648731.
      Citations: 7     Fields:    Translation:Humans
    39. Pieterse E, Rother N, Yanginlar C, Hilbrands LB, van der Vlag J. Neutrophils Discriminate between Lipopolysaccharides of Different Bacterial Sources and Selectively Release Neutrophil Extracellular Traps. Front Immunol. 2016; 7:484. PMID: 27867387.
      Citations: 57     Fields:    
    40. Dieker J, Berden JH, Bakker M, Briand JP, Muller S, Voll R, Sjöwall C, Herrmann M, Hilbrands LB, van der Vlag J. Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis. PLoS One. 2016; 11(10):e0165373. PMID: 27780265.
      Citations: 18     Fields:    Translation:HumansCells
    41. Peters-Sengers H, Berger SP, Heemskerk MB, Al Arashi D, Homan van der Heide JJ, Hemke AC, Ten Berge IJ, Idu MM, Betjes MG, van Zuilen AD, Hilbrands LB, de Vries AP, Nurmohamed AS, Christiaans MH, Ernest van Heurn LW, de Fijter JW, Bemelman FJ. Stretching the Limits of Renal Transplantation in Elderly Recipients of Grafts from Elderly Deceased Donors. J Am Soc Nephrol. 2017 Feb; 28(2):621-631. PMID: 27729570.
      Citations: 22     Fields:    Translation:Humans
    42. Stokman G, Kers J, Yapici Ü, Hoelbeek JJ, Claessen N, de Boer OJ, Netea MG, Hilbrands L, Bemelman FJ, Ten Berge IJ, Florquin S. Predominant Tubular Interleukin-18 Expression in Polyomavirus-Associated Nephropathy. Transplantation. 2016 10; 100(10):e88-95. PMID: 26863474.
      Citations: 6     Fields:    Translation:HumansCells
    43. Dobrowolski LC, van Huis M, van der Lee JH, Peters Sengers H, Liliën MR, Cransberg K, Cornelissen M, Bouts AH, de Fijter JW, Berger SP, van Zuilen A, Nurmohamed SA, Betjes MH, Hilbrands L, Hoitsma AJ, Bemelman FJ, Krediet CTP, Groothoff JW. Epidemiology and management of hypertension in paediatric and young adult kidney transplant recipients in The Netherlands. Nephrol Dial Transplant. 2016 11; 31(11):1947-1956. PMID: 27288460.
      Citations: 3     Fields:    Translation:Humans
    44. Göçeroglu A, Rahmattulla C, Berden AE, Reinders ME, Wolterbeek R, Steenbergen EJ, Hilbrands LB, Noorlander I, Berger SP, Peutz-Kootstra CJ, Christiaans MH, van Dijk MC, de Joode AA, Goldschmeding R, van Zuilen AD, Harper L, Little MA, Hagen EC, Bruijn JA, Bajema IM. The Dutch Transplantation in Vasculitis (DUTRAVAS) Study: Outcome of Renal Transplantation in Antineutrophil Cytoplasmic Antibody-associated Glomerulonephritis. Transplantation. 2016 Apr; 100(4):916-24. PMID: 26371598.
      Citations: 7     Fields:    Translation:Humans
    45. Assfalg V, Hüser N, van Meel M, Haller B, Rahmel A, de Boer J, Matevossian E, Novotny A, Knops N, Weekers L, Friess H, Pratschke J, Függer R, Janko O, Rasoul-Rockenschaub S, Bosmans JL, Broeders N, Peeters P, Mourad M, Kuypers D, Slavicek J, Muehlfeld A, Sommer F, Viebahn R, Pascher A, van der Giet M, Zantvoort F, Woitas RP, Putz J, Grabitz K, Kribben A, Hauser I, Pisarski P, Weimer R, Lorf T, Fornara P, Morath C, Nashan B, Lehner F, Kliem V, Sester U, Grimm MO, Feldkamp T, Kleinert R, Arns W, Mönch C, Schoenberg MB, Nitschke M, Krüger B, Thorban S, Arbogast HP, Wolters HH, Maier T, Lutz J, Heller K, Banas B, Hakenberg O, Kalus M, Nadalin S, Keller F, Lopau K, Bemelman FJ, Nurmohamed S, Sanders JS, de Fijter JW, Christiaans M, Hilbrands L, Betjes M, van Zuilen A, Heemann U. High-urgency kidney transplantation in the Eurotransplant Kidney Allocation System: success or waste of organs? The Eurotransplant 15-year all-centre survey. Nephrol Dial Transplant. 2016 09; 31(9):1515-22. PMID: 26908765.
      Citations: 1     Fields:    Translation:Humans
    46. Dieker J, Tel J, Pieterse E, Thielen A, Rother N, Bakker M, Fransen J, Dijkman HB, Berden JH, de Vries JM, Hilbrands LB, van der Vlag J. Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis. Arthritis Rheumatol. 2016 Feb; 68(2):462-72. PMID: 26360137.
      Citations: 57     Fields:    Translation:HumansCells
    47. Yapici Ü, Kers J, Slavujevic-Letic I, Stokman G, Roelofs JJ, van Aalderen MC, Groothoff JW, de Boer OJ, van der Pant KA, Claessen N, Hilbrands LB, Bemelman FJ, Ten Berge IJ, Florquin S. Intragraft Blood Dendritic Cell Antigen-1-Positive Myeloid Dendritic Cells Increase during BK Polyomavirus-Associated Nephropathy. J Am Soc Nephrol. 2016 Aug; 27(8):2502-10. PMID: 26701980.
      Citations: 3     Fields:    Translation:HumansCells
    48. Kamburova EG, van den Hoogen MW, Koenen HJ, Baas MC, Hilbrands LB, Joosten I. Cytokine Release After Treatment With Rituximab in Renal Transplant Recipients. Transplantation. 2015 Sep; 99(9):1907-11. PMID: 25675201.
      Citations: 3     Fields:    Translation:HumansCells
    49. Michelo CM, van der Meer A, Tijssen HJ, Zomer R, Stelma F, Hilbrands LB, Joosten I. KIR and Human Leukocyte Antigen Genotype Associated Risk of Cytomegalovirus Disease in Renal Transplant Patients. Transplantation. 2015 Jul; 99(7):1506-13. PMID: 25427165.
      Citations: 4     Fields:    Translation:Humans
    50. Dieker J, Hilbrands L, Thielen A, Dijkman H, Berden JH, van der Vlag J. Enhanced activation of dendritic cells by autologous apoptotic microvesicles in MRL/lpr mice. Arthritis Res Ther. 2015 Apr 16; 17:103. PMID: 25886192.
      Citations: 15     Fields:    Translation:AnimalsCells
    51. van Boekel GA, Aarnoutse RE, Hoogtanders KE, Havenith TR, Hilbrands LB. Delayed trough level measurement with the use of prolonged-release tacrolimus. Transpl Int. 2015 Mar; 28(3):314-8. PMID: 25474192.
      Citations: 3     Fields:    Translation:Humans
    52. Kamburova EG, Koenen HJ, van den Hoogen MW, Baas MC, Joosten I, Hilbrands LB. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS One. 2014; 9(11):e112658. PMID: 25393622.
      Citations: 17     Fields:    Translation:HumansCells
    53. Valke LL, van Cranenbroek B, Hilbrands LB, Joosten I. Soluble CD30 does not predict late acute rejection or safe tapering of immunosuppression in renal transplantation. Transpl Immunol. 2015 Jan; 32(1):18-22. PMID: 25446808.
      Citations: 3     Fields:    Translation:Humans
    54. Hilbrands L. On the occasion of the 25th anniversary of the Dutch Transplantation Society. Transpl Immunol. 2014 Oct; 31(4):183. PMID: 25251514.
      Citations:    Fields:    
    55. ten Berge I, Heutinck K, Yapici U, Stokman G, Florquin S, van Kooten C, Garcia-Romo G, Ruben J, van de Vrie M, Hilbrands L, Michelo C, Joosten I, van den Heuvel H, Claas F. The interplay between antiviral immunity and allo-immune reactivity after renal transplantation: consortium between the Centres Amsterdam, Leiden and Nijmegen (ALLOVIR). Transpl Immunol. 2014 Oct; 31(4):191-4. PMID: 25239648.
      Citations: 1     Fields:    Translation:HumansCells
    56. Roodnat JI, Hilbrands LB, Hené RJ, de Sévaux RG, Smak Gregoor PJ, Kal-van Gestel JA, Konijn C, van Zuilen A, van Gelder T, Hoitsma AJ, Weimar W. 15-year follow-up of a multicenter, randomized, calcineurin inhibitor withdrawal study in kidney transplantation. Transplantation. 2014 Jul 15; 98(1):47-53. PMID: 24521775.
      Citations: 12     Fields:    Translation:Humans
    57. van de Vrie M, Deegens JK, van der Vlag J, Hilbrands LB. Effect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL). Am J Kidney Dis. 2014 Apr; 63(4):573-6. PMID: 24268306.
      Citations: 8     Fields:    Translation:HumansCells
    58. van Boekel GA, Kerkhofs CH, Hilbrands LB. Treatment satisfaction in renal transplant patients taking tacrolimus once daily. Clin Ther. 2013 Nov; 35(11):1821-9.e1. PMID: 24135441.
      Citations: 8     Fields:    Translation:Humans
    59. Smeekens SP, van den Hoogen MW, Kamburova EG, van de Veerdonk FL, Joosten I, Koenen HJ, Netea MG, Hilbrands LB, Joosten LA. The effects of in vivo B-cell depleting therapy on ex-vivo cytokine production. Transpl Immunol. 2013 Jun; 28(4):183-8. PMID: 23651756.
      Citations: 3     Fields:    Translation:HumansCells
    60. Kamburova EG, Koenen HJ, Joosten I, Hilbrands LB. CD19 is a useful B cell marker after treatment with rituximab: comment on the article by Jones et al. Arthritis Rheum. 2013 Apr; 65(4):1130-1. PMID: 23335076.
      Citations: 4     Fields:    Translation:HumansCells
    61. van den Hoogen MW, van der Hoeven AM, Hilbrands LB. Insulin requirement after a renal transplant in patients with type 2 diabetes: the choice of calcineurin inhibitors. Exp Clin Transplant. 2013 Jun; 11(3):234-8. PMID: 23432070.
      Citations: 1     Fields:    Translation:Humans
    62. van den Hoogen MW, Kho MM, Abrahams AC, van Zuilen AD, Sanders JS, van Dijk M, Hilbrands LB, Weimar W, Hoitsma AJ. Effect of a single intraoperative high-dose ATG-Fresenius on delayed graft function in donation after cardiac-death donor renal allograft recipients: a randomized study. Exp Clin Transplant. 2013 Apr; 11(2):134-41. PMID: 23431996.
      Citations: 2     Fields:    Translation:HumansCells
    63. van Boekel GA, Aarnoutse RE, van der Heijden JJ, Hoogtanders KE, Hilbrands LB. Effect of mild diarrhea on tacrolimus exposure. Transplantation. 2012 Oct 15; 94(7):763-7. PMID: 22955188.
      Citations: 4     Fields:    Translation:Humans
    64. van den Hoogen MW, Hoitsma AJ, Hilbrands LB. Anti-T-cell antibodies for the treatment of acute rejection after renal transplantation. Expert Opin Biol Ther. 2012 Aug; 12(8):1031-42. PMID: 22583145.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    65. Hilbrands LB. Current perspectives to overcome a positive crossmatch in living donor renal transplantation. Transpl Int. 2012 May; 25(5):503-5. PMID: 22471344.
      Citations:    Fields:    Translation:Humans
    66. Fransen JH, Berden JH, Koeter CM, Adema GJ, Van Der Vlag J, Hilbrands LB. Effect of administration of apoptotic blebs on disease development in lupus mice. Autoimmunity. 2012 Jun; 45(4):290-7. PMID: 22390780.
      Citations: 5     Fields:    Translation:AnimalsCells
    67. van den Hoogen MW, Hilbrands LB. Use of monoclonal antibodies in renal transplantation. Immunotherapy. 2011 Jul; 3(7):871-80. PMID: 21751955.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    68. Gommers DG, Hilbrands L. What to do with a failed renal allograft: take it or leave it? Transpl Int. 2011 Jul; 24(7):e54. PMID: 21371135.
      Citations:    Fields:    Translation:Humans
    69. Jacobs JF, Punt CJ, Lesterhuis WJ, Sutmuller RP, Brouwer HM, Scharenborg NM, Klasen IS, Hilbrands LB, Figdor CG, de Vries IJ, Adema GJ. Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients. Clin Cancer Res. 2010 Oct 15; 16(20):5067-78. PMID: 20736326.
      Citations: 84     Fields:    Translation:HumansCellsCTClinical Trials
    70. van den Hoogen MW, Hilbrands LB. Single-dose rituximab as induction in renal transplantation. Transplantation. 2010 May 27; 89(10):1295; author reply 1295. PMID: 20555227.
      Citations:    Fields:    Translation:HumansCells
    71. Fransen JH, van der Vlag J, Ruben J, Adema GJ, Berden JH, Hilbrands LB. The role of dendritic cells in the pathogenesis of systemic lupus erythematosus. Arthritis Res Ther. 2010; 12(2):207. PMID: 20423534.
      Citations: 28     Fields:    Translation:HumansAnimalsCells
    72. de Winter BC, van Gelder T, Mathot RA, Glander P, Tedesco-Silva H, Hilbrands L, Budde K, van Hest RM. Limited sampling strategies drawn within 3 hours postdose poorly predict mycophenolic acid area-under-the-curve after enteric-coated mycophenolate sodium. Ther Drug Monit. 2009 Oct; 31(5):585-91. PMID: 19704401.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    73. van den Hoogen MW, Hilbrands LB. More on B-cell-depleting induction therapy and acute cellular rejection. N Engl J Med. 2009 Sep 17; 361(12):1215; author reply 1215-6. PMID: 19771606.
      Citations: 1     Fields:    Translation:HumansCells
    74. Peters JH, Koenen HJ, Hilbrands LB, Joosten I. Immunotherapy with regulatory T cells in transplantation. Immunotherapy. 2009 Sep; 1(5):855-71. PMID: 20636028.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    75. Fransen JH, Hilbrands LB, Ruben J, Stoffels M, Adema GJ, van der Vlag J, Berden JH. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17. Arthritis Rheum. 2009 Aug; 60(8):2304-13. PMID: 19644874.
      Citations: 47     Fields:    Translation:HumansAnimalsCells
    76. Peters HP, Hilbrands LB. Urinary albumin-total protein ratio: a new diagnostic tool to differentiate glomerular from nonglomerular hematuria? Am J Kidney Dis. 2009 Jan; 53(1):180. PMID: 19101401.
      Citations:    Fields:    Translation:Humans
    77. Peters JH, Preijers FW, Woestenenk R, Hilbrands LB, Koenen HJ, Joosten I. Clinical grade Treg: GMP isolation, improvement of purity by CD127 Depletion, Treg expansion, and Treg cryopreservation. PLoS One. 2008 Sep 08; 3(9):e3161. PMID: 18776930.
      Citations: 49     Fields:    Translation:HumansCells
    78. van den Hoogen MW, Verbruggen BW, Polenewen R, Hilbrands LB, Nováková IR. Use of the platelet function analyzer to minimize bleeding complications after renal biopsy. Thromb Res. 2009; 123(3):515-22. PMID: 18703219.
      Citations: 2     Fields:    Translation:Humans
    79. Kreijveld E, Koenen HJ, van Cranenbroek B, van Rijssen E, Joosten I, Hilbrands LB. Immunological monitoring of renal transplant recipients to predict acute allograft rejection following the discontinuation of tacrolimus. PLoS One. 2008 Jul 16; 3(7):e2711. PMID: 18628993.
      Citations: 11     Fields:    Translation:HumansCells
    80. van den Hoogen M, Hilbrands L. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med. 2008 Jun 05; 358(23):2519; author reply 2519-20. PMID: 18536099.
      Citations: 1     Fields:    Translation:Humans
    81. Peters JH, Hilbrands LB, Koenen HJ, Joosten I. Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapy. PLoS One. 2008 May 21; 3(5):e2233. PMID: 18493605.
      Citations: 40     Fields:    Translation:HumansCells
    82. de Winter BC, van Gelder T, Glander P, Cattaneo D, Tedesco-Silva H, Neumann I, Hilbrands L, van Hest RM, Pescovitz MD, Budde K, Mathot RA. Population pharmacokinetics of mycophenolic acid : a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients. Clin Pharmacokinet. 2008; 47(12):827-38. PMID: 19026038.
      Citations: 21     Fields:    Translation:Humans
    83. Kreijveld E, Hilbrands LB, van Berkel Y, Joosten I, Allebes W. The presence of donor-specific human leukocyte antigen antibodies does not preclude successful withdrawal of tacrolimus in stable renal transplant recipients. Transplantation. 2007 Nov 15; 84(9):1092-6. PMID: 17998862.
      Citations:    Fields:    Translation:Humans
    84. Kreijveld E, van der Meer A, Tijssen HJ, Hilbrands LB, Joosten I. KIR gene and KIR ligand analysis to predict graft rejection after renal transplantation. Transplantation. 2007 Oct 27; 84(8):1045-51. PMID: 17989611.
      Citations: 6     Fields:    Translation:HumansCells
    85. Coenen JJ, Koenen HJ, Emmer PM, van Rijssen E, Hilbrands LB, Joosten I. Allogeneic stimulation of naturally occurring CD4+CD25+ T cells induces strong regulatory capacity with increased donor-reactivity. Transpl Immunol. 2007 Jun; 17(4):237-42. PMID: 17493525.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    86. Hoitsma AJ, Hilbrands LB. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression. Clin Transplant. 2006 Sep-Oct; 20(5):659-64. PMID: 16968494.
      Citations: 4     Fields:    Translation:Humans
    87. Kreijveld E, Koenen HJ, Hilbrands LB, van Hooff HJ, Joosten I. The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4+ CD25- T cells. Blood. 2007 Jan 01; 109(1):244-52. PMID: 16902146.
      Citations: 7     Fields:    Translation:HumansCells
    88. Kreijveld E, Koenen HJ, Hilbrands LB, Joosten I. Ex vivo expansion of human CD4+ CD25high regulatory T cells from transplant recipients permits functional analysis of small blood samples. J Immunol Methods. 2006 Jul 31; 314(1-2):103-13. PMID: 16860335.
      Citations: 10     Fields:    Translation:HumansCells
    89. Nulens E, De Laere E, Vandevelde H, Hilbrands LB, Rijs AJ, Melchers WJ, Verweij PE. Alternaria infectoria phaeohyphomycosis in a renal transplant patient. Med Mycol. 2006 Jun; 44(4):379-82. PMID: 16772234.
      Citations: 4     Fields:    Translation:HumansAnimals
    90. Emmer PM, van der Vlag J, Adema GJ, Hilbrands LB. Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness. Transplantation. 2006 May 27; 81(10):1451-9. PMID: 16732184.
      Citations: 32     Fields:    Translation:AnimalsCells
    91. Hilbrands LB, Wetzels JF. Long-term outcome of renal transplantation from older donors. N Engl J Med. 2006 May 11; 354(19):2071-4; author reply 2071-4. PMID: 16696144.
      Citations:    Fields:    Translation:Humans
    92. Coenen JJ, Koenen HJ, van Rijssen E, Boon L, Joosten I, Hilbrands LB. CTLA-4 engagement and regulatory CD4+CD25+ T cells independently control CD8+-mediated responses under costimulation blockade. J Immunol. 2006 May 01; 176(9):5240-6. PMID: 16621989.
      Citations: 6     Fields:    Translation:AnimalsCells
    93. Coenen JJ, Koenen HJ, van Rijssen E, Hilbrands LB, Joosten I. Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells. Blood. 2006 Feb 01; 107(3):1018-23. PMID: 16210336.
      Citations: 86     Fields:    Translation:HumansCells
    94. Hilbrands LB, Huysmans FT, Wetzels JF. Screening for microalbuminuria. Kidney Int. 2005 Oct; 68(4):1899-901; author reply 1901-2. PMID: 16164673.
      Citations:    Fields:    Translation:HumansPHPublic Health
    95. Hilbrands L, Hoitsma A, Wetzels J. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med. 2005 May 12; 352(19):2027-8; author reply 2027-8. PMID: 15888709.
      Citations: 5     Fields:    Translation:Humans
    96. Coenen JJ, Koenen HJ, van Rijssen E, Hilbrands LB, Joosten I. Tolerizing effects of co-stimulation blockade rest on functional dominance of CD4+CD25+ regulatory T cells. Transplantation. 2005 Jan 27; 79(2):147-56. PMID: 15665762.
      Citations: 6     Fields:    Translation:AnimalsCells
    97. Artz MA, Hilbrands LB, Borm G, Assmann KJ, Wetzels JF. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy. Nephrol Dial Transplant. 2004 Nov; 19(11):2852-7. PMID: 15466882.
      Citations: 8     Fields:    Translation:Humans
    98. ter Meulen CG, van Riemsdijk I, Hené RJ, Christiaans MH, Borm GF, Corstens FH, van Gelder T, Hilbrands LB, Weimar W, Hoitsma AJ. No important influence of limited steroid exposure on bone mass during the first year after renal transplantation: a prospective, randomized, multicenter study. Transplantation. 2004 Jul 15; 78(1):101-6. PMID: 15257046.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    99. ter Meulen CG, Hilbrands LB, van den Bergh JP, Hermus AR, Hoitsma AJ. The influence of corticosteroids on quantitative ultrasound parameters of the calcaneus in the 1st year after renal transplantation. Osteoporos Int. 2005 Mar; 16(3):255-62. PMID: 15232677.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    100. Artz MA, Boots JM, Ligtenberg G, Roodnat JI, Christiaans MH, Vos PF, Moons P, Borm G, Hilbrands LB. Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. Am J Transplant. 2004 Jun; 4(6):937-45. PMID: 15147428.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    101. ter Meulen CG, van Riemsdijk I, Hené RJ, Christiaans MH, Borm GF, van Gelder T, Hilbrands LB, Weimar W, Hoitsma AJ. Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study. Am J Transplant. 2004 May; 4(5):803-10. PMID: 15084178.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    102. ter Meulen CG, Jacobs CW, Wetzels JF, Klasen IS, Hilbrands LB, Hoitsma AJ. The fractional excretion of soluble interleukin-2 receptor-alpha is an excellent predictor of the interleukin-2 receptor-alpha status after treatment with daclizumab. Transplantation. 2004 Jan 27; 77(2):281-6. PMID: 14742994.
      Citations:    Fields:    Translation:Humans
    103. ter Meulen CG, Göertz JH, Klasen IS, Verweij CM, Hilbrands LB, Wetzels JF, Hoitsma AJ. Decreased renal excretion of soluble interleukin-2 receptor alpha after treatment with daclizumab. Kidney Int. 2003 Aug; 64(2):697-703. PMID: 12846768.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    104. Artz MA, Boots JM, Ligtenberg G, Roodnat JI, Christiaans MH, Vos PF, Blom HJ, Sweep FC, Demacker PN, Hilbrands LB. Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus. J Am Soc Nephrol. 2003 Jul; 14(7):1880-8. PMID: 12819249.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    105. van Pel M, Hilbrands L, Smits D, van Breugel DW, van Eck M, Boog CJ. Permanent acceptance of both cardiac and skin allografts using a mild conditioning regimen for the induction of stable mixed chimerism in mice. Transpl Immunol. 2003 Jan-Mar; 11(1):57-63. PMID: 12727476.
      Citations:    Fields:    Translation:Animals
    106. Willems HL, Hilbrands LB, van de Calseyde JF, Monnens LA, Swinkels DW. Is serum cystatin C the marker of choice to predict glomerular filtration rate in paediatric patients? Ann Clin Biochem. 2003 Jan; 40(Pt 1):60-4. PMID: 12542911.
      Citations: 9     Fields:    Translation:Humans
    107. Smak Gregoor PJ, de Sévaux RG, Ligtenberg G, Hoitsma AJ, Hené RJ, Weimar W, Hilbrands LB, van Gelder T. Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study. J Am Soc Nephrol. 2002 May; 13(5):1365-73. PMID: 11961025.
      Citations: 24     Fields:    Translation:HumansCTClinical Trials
    Hilbrands's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (205)
    Explore
    _
    Co-Authors (76)
    Explore
    _
    Similar People (60)
    Explore
    _